Mast cell subpopulations in gingival overgrowth induced by immunosuppressive and nifedipine medication

Journal of Periodontology

Volumn 75, Issue 7, 2004, Pages 933-938

  Nurmenniemi, Petri K ^a   Pernu, Hilkka E ^a,b   Knuuttila, Matti L E ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Chymase; Cyclosporin A adverse effects; Gingival hyperplasia etiology; Immunosuppressive agents adverse effects; Mast cells; Nifedipine adverse effects; Tryptase

Indexed keywords

AVIDIN; AZATHIOPRINE; BIOTIN; CHYMASE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; NIFEDIPINE; TRYPTASE;

ADULT; AGED; ARTICLE; CELL COUNT; CELL SUBPOPULATION; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FROZEN SECTION; GINGIVA OVERGROWTH; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KRUSKAL WALLIS TEST; MALE; MAST CELL; MOUTH MUCOSA; ORGAN TRANSPLANTATION; OUTPATIENT; RANK SUM TEST; RECIPIENT; SAMPLING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CASE-CONTROL STUDIES; CELL COUNT; CYCLOSPORINE; FEMALE; GINGIVA; GINGIVAL OVERGROWTH; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MAST CELLS; MIDDLE AGED; NIFEDIPINE; STATISTICS, NONPARAMETRIC;

EID: 4444238272     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.7.933     Document Type: Article

References (27)

1. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996;23:165-175.
2. Seymour RA. Calcium channel blockers and gingival overgrowth. Br Dent J 1991;170:376-379.
3. Ellis JS, Seymour RA, Steele JG, Robertson P, Butler T, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: A community-based study. J Periodontol 1999;70:63-67.
4. Pernu HE, Pernu HLM, Knuuttila MLE. Effect of periodontal treatment on gingival overgrowth among cyclosporine A-treated renal transplant recipients. J Periodontol 1993;64:1098-1100.
5. Bökenkamp A, Bohnhorst B, Beier C, Albers N, Offner G, Brodehl J. Nifedipine aggravates cyclosporine A-induced gingival hyperplasia. Pediatr Nephrol 1994; 8:181-185.
6. Thomason JM, Seymour RA, Ellis JS, et al. Iatrogenic gingival overgrowth in cardiac transplantation. J Periodontol 1995;66:742-746.
7. Nurmenniemi PK, Pernu HE, Knuuttila MLE. Density of CD1a-labeled Langerhans' cells in normal human gingiva and in nifedipine- and immunosuppressive medication-induced gingival overgrowth. J Periodontol 1999;70: 752-756.
8. Pernu HE, Knuuttila MLE. Macrophages and lymphocyte subpopulations in nifedipine- and cyclosporin A-associated human gingival overgrowth, J Periodontol 2001;72: 160-166.
9. Nurmenniemi PK, Pernu HE, Laukkanen P, Knuuttila MLE. Macrophage subpopulations in overgrown gingiva induced by nifedipine and immunosuppressive medication. J Periodontol 2002;73:1323-1330.
10. Krishnaswamy G, Kelley J, Johnson D, et al. The human mast cell: Functions in physiology and disease. Front Biosci 2001;6:1109-1127.
11. Irani AA, Schechter NM, Graig S, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci (USA) 1986; 83:4464-4468.
12. Weidner N, Austen KF. Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content. Pathol Res Pract 1993;189:156-162.
13. TC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 1989;37:1509-1515.
14. Galli SJ, Mauer M, Lanz CS. Mast cells as sentinels of innate immunity. Curr Opin Immunol 1999;11:53-59.
15. Welle M. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol 1997;61: 233-245.
16. Sperr WR, Agis H, Czerwenka K, et al. Effects of cyclosporin A and FK-506 on stem cell factor-induced histamine secretion and growth of human mast cells. J Allergy Clin Immunol 1996;98:389-399.
17. Hatfield SM, Roehm NW. Cyclosporine and FK506 inhibition of murine mast cell cytokine production. J Pharmacol Exp Ther 1992;260:680-688.
18. Fumihiko I, Toyota N, Sakai H, Takahashi H, Iizuka H. FK506 and cyclosporin A inhibit stem cell factor-dependent cell proliferation/survival, while inducing up-regulation of c-kit expression in cells of the mast cell line MC/9. Arch Dermatol Res 1999;291:275-283.
19. Asahara Y, Nishimura F, Yamada H, et al. Mast cells are not involved in the development of cyclosporin A-induced gingival hyperplasia: A study with mast cell-deficient mice. J Periodontol 2000;71:1117-1120.
20. Warbrick EV, Thomas AL, Williams CMM. The effects of cyclosporin A, dexamethasone and other immunomodulatory drugs on induced expression of IL-3, IL-4 and IL-8 mRNA in a human mast cell line. Toxicology 1997; 116:211-218.
21. Ihle JN, Keller J, Oroszlan S, et al. Biological properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth-factor activity, mast cell growth factor activity, P cell-stimulating activity and histamine-producing activity J Immunol 1983;131:282-287.
22. Kaye RE, Fruman DA, Bierer BE, et al. Effects of cyclosporin A and FK506 on fc receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: Resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. Proc Natl Acad Sci (USA) 1992;89:8542-8546.
23. Pernu HE, Pernu LM, Huttunen KR, Nieminen PA, Knuuttila MLE. Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 1992;63: 548-53.
24. Nurmenniemi PK, Pernu HE, Knuuttila MLE. Mitotic activity of keratinocytes in nifedipine- and immunosuppressive medication-induced gingival overgrowth. J Periodontol 2001;72:167-173.
25. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST. Heterogeneity of human mast cells based on cytokine content. J Immunol 1995;155:297-307.
26. Saarinen J, Kalkkinen N, Welgus HG, Kovanen PT. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J Biol Chem 1994;269:18134-18140.
27. Roberts ISD, Brenchley BEC. Mast cells: The forgotten cells of renal fibrosis. J Clin Pathol 2000;53:858-862.